WPRIM Management System> DCMS> Journal of Breast Cancer> 2005> 8

Volume: 8

1. Adenoid Cystic Carcinoma of the Breast associated with Adenomyoepithelioma. Page:99—102
2. Axillary Web Syndrome after Sentinel Node Biopsy and Axillary Lymph Node Dissection during the Conservative Treatment of Early Breast Cancer. Page:94—98
3. Reduction Mammoplasty is a Functional Operation, for Improving the Quality of Life in Symptomatic Women - MDbP301. Page:89—93
4. Partial Breast Irradiation Using Brachy-therapy after Breast Conserving Surgery. Page:83—88
5. Clinical Study of Breast Cancer Patients Who Had More Than 10 Positive Axillary Lymph Nodes. Page:76—82
6. The Evaluation of the Efficacy and the Safety of Docetaxel in Korean Breast Cancer Patients: through Post-Authori- zation Survey to Fulfill the Registrative Requirement. Page:68—75
7. Prognostic Factors Predicting the Survival of Breast Cancer Patients with Metastases or Recurrences: Clinicopathologic Characteristics of Primary Tumor. Page:62—67
8. The Relationship between Abnormal Screening Bone Scintigraphy and Bone Metastasis in Breast Cancer Patients. Page:56—61
9. Expression of the c-met Gene in Invasive Ductal Carcinomas. Page:48—55
10. Correlation of the Immunohistochemical Coexpression of p53 and HER-2/neu and the Prognosis of Breast Cancer. Page:41—47
11. A Comparative Study of Cyclooxygenase-2 Expression in Korean and Caucasian Patients with Early-Onset Breast Cancer. Page:34—40
12. Prognostic Value for the S-phase fraction in T1 T2, Node Negative Breast Cancer. Page:27—33
13. Cathepsin D expression in the tumor cells and juxta-tumoral stromal cells of T1 invasive ductal carcinoma, Nos. Page:17—26
14. Glycobiology of Selectin. Page:4—16
15. Combined Multimodality Treatment including Surgery. Page:69—73
16. Granulomatous mastitis. Page:64—68
17. Hemangioma of the Breast: a Case Report. Page:213—216
18. Incidentally detected insitu ductal carcinoma with mastitis. Page:209—212
19. Surgery for Small Breast Cancer Considering Functional and Cosmetic Aspect. Page:205—208
20. Quality of Life for Patients who had Breast Cancer Operations: The Validity and Availability for WHOQOL-BREF. Page:199—204
21. The Utility of Modified Triple Test for Preoperative Diagnosis of Breast Diseases. Page:193—198
22. Synergistic Cytotoxic Effects of Zole-dronic Acid and Radiation in the MCF-7 Human Breast Cancer Cell Line. Page:186—192
23. Recurrence and Survival Analysis in Skin-Sparing Mastectomy with Immediate Reconstruction Compared with Conventional Mastectomy. Page:178—185
24. correlation between c-erbB-2 expression and other prognostic factors in breast cancer. Page:172—177
25. Proliferative Markers of Breast Cancer. Page:165—171
26. Loss of Heterozygosity of E-Cadherin Gene and Protein Expression in Invasive Ductal Carcinomas. Page:157—164
27. Cellular localization of MUC1 in Benign and Malignant Breast Lesions with the Histological Correlation and the Prognostic Significance. Page:150—156
28. The Highligts of 28th Annual Meeting of San Antonio Breast Cancer Symposium. Page:142—149
29. A case of phyllodes tumor in a 10-year-old girl. Page:138—141
30. Three Cases of Elderly Women with Breast Cancer treated with Non-operative Methods. Page:134—137
31. Clinical review of bilateral breast cancer. Page:128—133
32. Male Breast Cancer. Page:123—127
33. Effect of intracapsular triamcinolone injection in treatment of capsular contracture after augmentation mammoplasty. Page:118—122
34. Clinical Significance of Solitary Costal Hot Spot on Postoperative Bone Scan in Patients with Breast Cancer. Page:113—117
35. The effect of growth factor receptor HER2 on the estrogen receptor transcriptional activities and its implications. Page:105—112
36. Comparison of estrogen receptor beta expression between breast cancer and normal mammary tissue and relationship with clinicopathological factors. Page:99—104
37. Excision of benign breast tumor by an Ultrasound-Guided hand held Mammotome biopsy device. Page:92—98
38. Immunohistochemical localization of beta human chorionic gonadotrophin (beta-hCG) in breast carcinomas and its prognostic significance. Page:86—91
39. Prediction of Future Occurrence and Probability of Developing Breast Cancer over Lifespan in Korean Women. Page:80—85
40. The Clinicopathologic Characteristics of 38 Metaplastic Carcinomas of the Breast. Page:59—63
41. The Clinicopathologic Characteristics of 38 Metaplastic Carcinomas of the Breast. Page:59—63
42. Clinical Significance of DAX-1 Expression using Immunihistochemical Staining in Breast Cancer. Page:52—58
43. Clinical Significance of DAX-1 Expression using Immunihistochemical Staining in Breast Cancer. Page:52—58
44. Expression of estrogen receptor beta, estrogen receptor alpha and cyclooxygenase II in advanced breast cancer. Page:45—51
45. Expression of estrogen receptor beta, estrogen receptor alpha and cyclooxygenase II in advanced breast cancer. Page:45—51
46. FAS (Fatty acid synthase) expression in breast cancer. Page:40—44
47. FAS (Fatty acid synthase) expression in breast cancer. Page:40—44
48. Detection of micrometastasis in fixed paraffin-embedded Sentinel Lymph Nodes of Breast cancer using RT-PCR. Page:31—39
49. Detection of micrometastasis in fixed paraffin-embedded Sentinel Lymph Nodes of Breast cancer using RT-PCR. Page:31—39
50. Survival Analyses in Breast Cancer According to Over-expression and Amplification of HER2. Page:23—30
51. Survival Analyses in Breast Cancer According to Over-expression and Amplification of HER2. Page:23—30
52. Overexpression of the Bmi-1 Oncoprotein correlates with Axillary Lymph Node Metastases in Invasive Ductal Breast Cancer. Page:17—22
53. Overexpression of the Bmi-1 Oncoprotein correlates with Axillary Lymph Node Metastases in Invasive Ductal Breast Cancer. Page:17—22
54. Characterization of the Differentially Expressed Genes in Human Breast Cancer using Subtractive Hybridization. Page:10—16
55. Characterization of the Differentially Expressed Genes in Human Breast Cancer using Subtractive Hybridization. Page:10—16
56. Tamoxifen Resistance and Crosstalk of Signal Transduction in Breast Cancer. Page:4—9
57. Tamoxifen Resistance and Crosstalk of Signal Transduction in Breast Cancer. Page:4—9